Hervé Maisonneuve

2.5k citations

40 papers · 816 indexed · h-index 16

Co-authors: Jean François Rossignol Philippe Moreau Beatrice Mahé Jean‐François Rossignol Patrice Chevallier Steven Le Gouill Véronique Leblond Dominique Penther
Topics: Lymphoma Diagnosis and Treatment (19 papers)Chronic Lymphocytic Leukemia Research (15 papers)Acute Lymphoblastic Leukemia research (5 papers)
Cited by: Genetics Parasitology Pathology and Forensic Medicine
Journals: Blood Clinical Cancer Research Annals of Oncology
Partner nations: France United States Switzerland

In The Last Decade

Hervé Maisonneuve

40 papers receiving 785 citations

Peers

Countries citing papers authored by Hervé Maisonneuve

Since Specialization

Citations

This map shows the geographic impact of Hervé Maisonneuve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Maisonneuve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Maisonneuve more than expected).

Fields of papers citing papers by Hervé Maisonneuve

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Maisonneuve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Maisonneuve. The network helps show where Hervé Maisonneuve may publish in the future.

Co-authorship network of co-authors of Hervé Maisonneuve

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Maisonneuve. A scholar is included among the top collaborators of Hervé Maisonneuve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Maisonneuve. Hervé Maisonneuve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity 2023 ·Clinical Cancer Research ·Fabienne Desmots,Delphine Rossille,Mikaël Roussel,Céline Pangault,(unknown),(unknown),Steven Le Gouill,Krimo Bouabdallah,Vincent Delwail,Rémy Gressin,Jérôme Cornillon,Gandhi Damaj,Hervé Maisonneuve,Diane Damotte,Françoise Kraeber‐Bodéré,Thierry Lamy,Marie Parrens,Nöel Milpied,Thierry Fest	1
2	CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages 2019 ·Leukemia ·(unknown),Benoît Tessoulin,Céline Bellanger,Philippe Moreau,Yannick Le Bris,Hervé Maisonneuve,Cyrille Touzeau,Martine Amiot,Catherine Pellat‐Deceunynck,Steven Le Gouill,David Chiron	53
3	Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center 2014 ·Annals of Oncology ·Marion Loirat,Patrice Chevallier,Christophe Leux,Philippe Moreau,Céline Bossard,Thierry Guillaume,Thomas Gastinne,J. Delaunay,Nicolas Blin,Beatrice Mahé,Viviane Dubruille,Karine Augeul-Meunier,Pierre Péterlin,Hervé Maisonneuve,Nadine Juge‐Morineau,Henry Jardel,Mohamad Mohty,Steven Le Gouill	30
4	Rituximab Maintenance Versus Wait and Watch after Four Courses of R-DHAP Followed By Autologous Stem Cell transplantation in Previously Untreated Young Patients with Mantle Cell Lymphoma: First Interim Analysis of the Phase III Prospective Lyma Trial, a Lysa Study 2014 ·Blood ·Steven Le Gouill,Catherine Thiéblemont,Lucie Obéric,Krimo Bouabdallah,Emmanuel Gyan,Gandhi Damaj,Vincent Ribrag,Serge Bologna,Rémy Gressin,Olivier Casasnovas,Corinne Haïoun,Philippe Solal‐Céligny,Hervé Maisonneuve,Éric Van Den Neste,Philippe Moreau,Marie C. Béné,Gilles Salles,Hervé Tilly,Thierry Lamy,Olivier Hermine	26
5	La protéomique, une nouvelle technique pour un typage optimal des amyloses 2014 ·La Revue de Médecine Interne ·Magali Colombat,(unknown),(unknown),Sophie Valleix,Hervé Maisonneuve,Jean‐Emmanuel Kahn	1
6	Results of a Phase II Randomizing Intensified Rituximab Pre-Phase Followed By Standard FCR Vs Standard FCR in Previously Untreated Patients with Active B-Chronic Lymphocytic Leukemia (B-CLL). CLL2010FMP (for fit medically patients): A Study of the french Cooperative Group on CLL and WM (FCGCLL/MW) and the “Groupe Ouest-Est d’Etudes Des Leucémies Aigües Et Autres Maladies Du sang” (GOELAMS) 2014 ·Blood ·Stéphane Leprêtre,(unknown),Caroline Dartigeas,Hervé Maisonneuve,Thérèse Aurran,Pierre Feugier,Sophie de Guibert,(unknown),Bernadette Corront,Véronique Leblond,Alain Delmer,Anne-Laure Gagez,(unknown),(unknown),Florence Cymbalista,Guillaume Cartron,Emmanuelle Ferrant,Beatrice Mahé,Romain Guièze	2
7	A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma 2013 ·Leukemia & lymphoma ·Éric Jourdan,Véronique Leblond,Hervé Maisonneuve,Karim A. Benhadji,Anwar M. Hossain,Tuan S. Nguyen,James E. Wooldridge,Philippe Moreau	15
8	Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang 2012 ·British Journal of Haematology ·(unknown),(unknown),(unknown),(unknown),Samuel Duley,(unknown),(unknown),(unknown),Steven Le Gouill,Olivier Tournilhac,Éric Voog,Hervé Maisonneuve,Marie Christine Jacob,Dominique Leroux,Marie C. Béné,Christine Formisano‐Tréziny,Jean Gabert,Rémy Gressin,Mary Callanan	11
9	A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload 2011 ·Blood Cells Molecules and Diseases ·Edouard Bardou‐Jacquet,Marie‐Laure Island,Anne‐Marie Jouanolle,Lénaı̈ck Détivaud,(unknown),Martine Ropert,Éolia Brissot,Annick Mosser,Hervé Maisonneuve,Pierre Brissot,Olivier Loréal	40
10	No Benefit of First-Line Rituximab (R) - High-Dose Therapy (R-HDT) Over R-CHOP14 for Young Adults with Diffuse Large B-Cell Lymphoma. Preliminary Results of the GOELAMS 075 Prospective Multicentre Randomized Trial 2010 ·Blood ·Nöel Milpied,Steven Le Gouill,Thierry Lamy,Vincent Delwail,Rémy Gressin,Denis Guyotat,Gandhi Damaj,Charles Foussard,Philippe Quittet,Hervé Maisonneuve,Éric Deconinck,François Dreyfus,Emmanuel Gyan,Laurent Sutton,Nadine Morineau,Magda Alexis,(unknown),(unknown)	13
11	Respective PROGNOSTIC Value of the International Harmonization PROJECT (IHP), Gallamini and London Criteria for Interim FDG PET-CT Performed AFTER 4 Courses of ABVD IN HODGKIN'S LYMPHOMA 2010 ·Blood ·Thomas Gastinne,Pierre‐Yves Le Roux,Caroline Bodet‐Milin,Beatrice Mahé,Viviane Dubruille,Nicolas Blin,Nadine Morineau,Hervé Maisonneuve,Philippe Moreau,Jean‐Luc Harousseau,Pierre‐Yves Salaün,Françoise Kraeber‐Bodéré,Steven Le Gouill	1
12	Hairy-cell leukemia with inaugural joint manifestations 2009 ·Joint Bone Spine ·Judith Raimbourg,Grégoire Cormier,(unknown),(unknown),(unknown),Hervé Maisonneuve	4
13	Long-term follow-up of a randomized trial of fludarabine–mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies 2005 ·Annals of Oncology ·C. Foussard,Philippe Colombat,Hervé Maisonneuve,Christian Berthou,Rémy Gressin,M.C. Rousselet,(unknown),B. Pignon,Beatrice Mahé,C Ghandour,B Desablens,Philippe Casassus,T. Lamy,Vincent Delwail,Éric Deconinck	14
14	Prospective Randomized Study Comparing MEMID with a Chop-Like Regimen in Elderly Patients with Aggressive Non-Hodgkin’s Lymphoma 2005 ·Oncology ·Emmanuel Chamorey,Rémy Gressin,Frédéric Peyrade,Jean François Rossi,G. Lepeu,C. Foussard,(unknown),Michel Fabbro,Bruno Richard,Vincent Delwail,Hervé Maisonneuve,Jean‐Pierre Vilque,Antoine Thyss	4
15	Front-Line High-Dose Chemotherapy (HDT) Combined with Rituximab for Adults with Aggressive Large B-Cell Lymphoma (DLBCL) : Goelams 074 Trial. 2004 ·Blood ·Nöel Milpied,T. Lamy,Philippe Casassus,(unknown),Rémy Gressin,Hervé Maisonneuve,Christine Le Maignan,Jean‐François Ramée,Olivier Tournilhac,(unknown),Éric Legouffe,Vincent Delwail,Philippe Colombat	2
16	CARDIAC PACEMAKERS 2000 ·International Journal of Technology Assessment in Health Care ·B. Cuzin,Gilbert Kirkorian,Hervé Maisonneuve	2
17	[Malignant non-Hodgkin's lymphoma of the cervix. A case report]. 1995 ·PubMed ·Nathaniel Winer,Hervé Maisonneuve,(unknown),P Sagot,Patrice Lopès,G. Boog,(unknown)	3
18	Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis 1985 ·Annals of Tropical Medicine and Parasitology ·Hervé Maisonneuve,Jean François Rossignol,(unknown),M Mojon	18
19	Benzimidazoles in the treatment of trichuriasis: a review 1984 ·Annals of Tropical Medicine and Parasitology ·Jean François Rossignol,Hervé Maisonneuve	29
20	Albendazole: a new concept in the control of intestinal helminthiasis. 1984 ·PubMed ·(unknown),Hervé Maisonneuve	11

About Hervé Maisonneuve

Hervé Maisonneuve is a scholar working on Genetics, Pathology and Forensic Medicine and Parasitology, having authored 40 papers that have together received 816 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Genetics (290 citations), Parasitology (154 citations) and Pathology and Forensic Medicine (357 citations). Hervé Maisonneuve has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Jean François Rossignol, Philippe Moreau, Beatrice Mahé, Jean‐François Rossignol, Patrice Chevallier, Steven Le Gouill, Véronique Leblond, Dominique Penther, M. Hamidou and Jean Luc Harousseau. Their work appears in journals such as Blood, Clinical Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact